Cutaneous hemophagocytosis after alemtuzumab injection in a patient with Sézary syndrome.

TitleCutaneous hemophagocytosis after alemtuzumab injection in a patient with Sézary syndrome.
Publication TypeJournal Article
Year of Publication2014
AuthorsJawed SI, Busam K, Wang X, Horwitz S, Querfeld C
JournalJAMA Dermatol
Volume150
Issue9
Pagination1021-3
Date Published2014 Sep
ISSN2168-6084
KeywordsAlemtuzumab, Antibodies, Monoclonal, Humanized, Antineoplastic Agents, Drug Eruptions, Female, Humans, Lymphohistiocytosis, Hemophagocytic, Middle Aged, Sezary Syndrome, Skin Diseases, Skin Neoplasms
DOI10.1001/jamadermatol.2013.10615
Alternate JournalJAMA Dermatol
PubMed ID25029560
Related Faculty: 
Xuan Wang, M.D., Ph.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700